Jincheng Pharmaceutical: Expected net profit growth of 51.19% to 85.42% year-on-year in the first quarter of 2026

Jincheng Pharmaceutical announces that it expects the net profit for the first quarter of 2026 to be between 53 million yuan and 65 million yuan, a year-on-year increase of 51.19% to 85.42%.
During the reporting period, the company’s net profit attributable to shareholders of the listed company increased compared to the same period last year, mainly due to higher sales volume of some products in the intermediate products segment and increased capacity utilization.
At the same time, the company continues to improve quality and efficiency internally, increase technological innovation, and promote high-quality development.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin